Age-dependent Loss of Parvalbumin-expressing Hippocampal Interneurons in Mice Deficient in CHL1, a Mental Retardation and Schizophrenia Susceptibility Gene
Overview
Authors
Affiliations
In humans, deletions/mutations in the CHL1/CALL gene are associated with mental retardation and schizophrenia. Juvenile CHL1-deficient (CHL1(-/-) ) mice have been shown to display abnormally high numbers of parvalbumin-expressing (PV(+) ) hippocampal interneurons and, as adults, display behavioral traits observed in neuropsychiatric disorders. Here, we addressed the question whether inhibitory interneurons and synaptic plasticity in the CHL1(-/-) mouse are affected during brain maturation and in adulthood. We found that hippocampal, but not neocortical, PV(+) interneurons were reduced with age in CHL1(-/-) mice, from a surplus of +27% at 1 month to a deficit of -20% in adulthood compared with wild-type littermates. This loss occurred during brain maturation, correlating with microgliosis and enhanced interleukin-6 expression. In parallel with the loss of PV(+) interneurons, the inhibitory input to adult CA1 pyramidal cells was reduced and a deficit in short- and long-term potentiation developed at CA3-CA1 excitatory synapses between 2 and 9 months of age in CHL1(-/-) mice. This deficit could be abrogated by a GABAA receptor agonist. We propose that region-specific aberrant GABAergic synaptic connectivity resulting from the mutation and a subsequently enhanced synaptic elimination during brain maturation lead to microgliosis, increase in pro-inflammatory cytokine levels, loss of interneurons, and impaired synaptic plasticity. Close homolog of L1-deficient (CHL1(-/-) ) mice have abnormally high numbers of parvalbumin (PV)-expressing hippocampal interneurons in juvenile animals, but in adult animals a loss of these cells is observed. This loss correlates with an increased density of microglia (M), enhanced interleukin-6 (IL6) production and a deficit in short- and long-term potentiation at CA3-CA1 excitatory synapses. Furthermore, adult CHL1(-/-) mice display behavioral traits similar to those observed in neuropsychiatric disorders of humans.
Aksic M, Jakovcevski I, Hamad M, Jakovljevic V, Stankovic S, Vulovic M Biomedicines. 2024; 12(8).
PMID: 39200191 PMC: 11351965. DOI: 10.3390/biomedicines12081726.
CHL1 depletion affects dopamine receptor D2-dependent modulation of mouse behavior.
Fernandes L, Kleene R, Congiu L, Freitag S, Kneussel M, Loers G Front Behav Neurosci. 2023; 17:1288509.
PMID: 38025382 PMC: 10665519. DOI: 10.3389/fnbeh.2023.1288509.
Aleksic D, Poleksic J, Agatonovic G, Djulejic V, Vulovic M, Aksic M Front Neurosci. 2023; 17:1187758.
PMID: 37434764 PMC: 10330809. DOI: 10.3389/fnins.2023.1187758.
Congiu L, Granato V, Jakovcevski I, Kleene R, Fernandes L, Freitag S Biomolecules. 2023; 13(5).
PMID: 37238646 PMC: 10216033. DOI: 10.3390/biom13050776.
Ferrer-Ferrer M, Jia S, Kaushik R, Schneeberg J, Figiel I, Aleshin S Cell Mol Life Sci. 2023; 80(4):82.
PMID: 36871239 PMC: 9986217. DOI: 10.1007/s00018-023-04720-z.